Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Asterand Signs Agreement To Acquire BioSeek
Asterand has signed an agreement to acquire BioSeek, subject to Asterand shareholders’ approval. The company said that a circular will be sent to shareholders once it has been
Asterand has signed an agreement to acquire BioSeek, subject to Asterand shareholders’ approval. The company said that a circular will be sent to shareholders once it has been
IsoRay has signed a distribution agreement with Inter V Medical of Montreal, Quebec, Canada. Inter V Medical will have rights to sell Cesium-131 brachytherapy seeds in Canada, which
Genzyme has reported results of a phase 2/3 study of its advanced phosphate binder (APB). The trial met its primary endpoint, which was to show that the APB
CytRx is going to initiate an open-label, multinational phase 2 clinical trial with its doxorubicin prodrug INNO-206, as a second-line treatment in patients with advanced gastric (stomach) cancer.
The 1st user meeting on protein arrays in clinical applications was organised by Protagen, Germany. It focused on the increasing relevance of new markers and marker panels for
Pfizer has reported that FDA’s Vaccines and Related Biological Products Advisory Committee voted 10 to 1 that the data presented support the safety and effectiveness of its 13-valent
Affiris will focus its Alzheimer’s vaccine program on one product candidate at an unexpectedly early stage of development that the vaccine candidate AD02 is planned to enter into
AstraZeneca has reported the results of the phase II studies, onset/offset and respond for Ticagrelor (Brilinta) at the annual American Heart Association (AHA) scientific sessions in Orlando, FL.
Millennium has expanded its protein homeostasis program with the initiation of Phase I clinical trial for an oral formulation of MLN9708, a proteasome inhibitor. An intravenous formulation of
The Food and Drug Administration (FDA) has warned patients against taking Nexium or Prilosec if they are already taking Plavix. Plavix, a prescribed blood thinner that protects against